FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

703797007: Ponatinib hydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3009699010 Ponatinib hydrochloride (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3009817013 Ponatinib hydrochloride en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ponatinib hydrochloride Is a Ponatinib false Inferred relationship Existential restriction modifier
Ponatinib hydrochloride Has disposition Protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier
Ponatinib hydrochloride Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Ponatinib hydrochloride Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Ponatinib hydrochloride Is a Benzamide false Inferred relationship Existential restriction modifier
Ponatinib hydrochloride Is modification of Ponatinib true Inferred relationship Existential restriction modifier
Ponatinib hydrochloride Is a Substance with protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Ponatinib hydrochloride Is a Substance with benzamide structure true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet Has active ingredient False Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely ponatinib (as ponatinib hydrochloride) 45 milligram/1 each conventional release oral tablet Has active ingredient False Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet Has active ingredient False Ponatinib hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely ponatinib (as ponatinib hydrochloride) 45 milligram/1 each conventional release oral tablet Has active ingredient False Ponatinib hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet Has precise active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely ponatinib (as ponatinib hydrochloride) 45 milligram/1 each conventional release oral tablet Has precise active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier 1
Product containing precisely ponatinib (as ponatinib hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier 1
Ponatinib 15mg tablets Has specific active ingredient False Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Ponatinib 45mg tablets Has specific active ingredient False Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 60 tablet Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Iclusig 15mg tablets (Ariad Pharma (UK) Ltd) 60 tablet Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Iclusig 45mg tablets (Ariad Pharma (UK) Ltd) 30 tablet Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Iclusig 15mg tablets (Ariad Pharma (UK) Ltd) Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Iclusig 45mg tablets (Ariad Pharma (UK) Ltd) Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Ponatinib 45mg tablets 30 tablet Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Product containing precisely ponatinib (as ponatinib hydrochloride) 45 milligram/1 each conventional release oral tablet Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets 30 tablet Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 30 tablet Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Iclusig 15mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has specific active ingredient True Ponatinib hydrochloride Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start